Human Rabies Vaccines Market, Global Outlook and Forecast 2022-2028

March 2022 | 79 pages | ID: H0EBDE3028DCEN
Market Monitor Global

Abstracts

Rabies vaccine is a vaccine used to prevent rabies.They can be used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite.The immunity that develops is long lasting after a full course.

This report contains market size and forecasts of Human Rabies Vaccines in global, including the following market information:

Global Human Rabies Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Human Rabies Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Human Rabies Vaccines companies in 2021 (%)

The global Human Rabies Vaccines market was valued at 1086.6 million in 2021 and is projected to reach US$ 1432.6 million by 2028, at a CAGR of 4.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Vero Cell Rabies Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Rabies Vaccines include Sanofi Pasteur?Inc., Novartis Vaccines and Diagnostics Ltd., Cadila Pharmaceuticals Ltd., GlaxoSmithKline Biologicals, Merck?Co Inc., Wyeth pharmaceuticals, Berna Biotech Ltd. and Medimmune LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Rabies Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Rabies Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Rabies Vaccines Market Segment Percentages, by Type, 2021 (%)

• Vero Cell Rabies Vaccine
• BHK
• Chick Embryo Cell Rabies Vaccine
• Others

Global Human Rabies Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Rabies Vaccines Market Segment Percentages, by Application, 2021 (%)

• Pre-Exposure Prophylaxis
• Post-Exposure Prophylaxis

Global Human Rabies Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Rabies Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Rabies Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Human Rabies Vaccines revenues share in global market, 2021 (%)

Key companies Human Rabies Vaccines sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Human Rabies Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi Pasteur?Inc.
• Novartis Vaccines and Diagnostics Ltd.
• Cadila Pharmaceuticals Ltd.
• GlaxoSmithKline Biologicals
• Merck?Co Inc.
• Wyeth pharmaceuticals
• Berna Biotech Ltd.
• Medimmune LLC

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Human Rabies Vaccines Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Human Rabies Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HUMAN RABIES VACCINES OVERALL MARKET SIZE

2.1 Global Human Rabies Vaccines Market Size: 2021 VS 2028
2.2 Global Human Rabies Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Rabies Vaccines Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Human Rabies Vaccines Players in Global Market
3.2 Top Global Human Rabies Vaccines Companies Ranked by Revenue
3.3 Global Human Rabies Vaccines Revenue by Companies
3.4 Global Human Rabies Vaccines Sales by Companies
3.5 Global Human Rabies Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Rabies Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Rabies Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Rabies Vaccines Players in Global Market
  3.8.1 List of Global Tier 1 Human Rabies Vaccines Companies
  3.8.2 List of Global Tier 2 and Tier 3 Human Rabies Vaccines Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Human Rabies Vaccines Market Size Markets, 2021 & 2028
  4.1.2 Vero Cell Rabies Vaccine
  4.1.3 BHK
  4.1.4 Chick Embryo Cell Rabies Vaccine
  4.1.5 Others
4.2 By Type - Global Human Rabies Vaccines Revenue & Forecasts
  4.2.1 By Type - Global Human Rabies Vaccines Revenue, 2017-2022
  4.2.2 By Type - Global Human Rabies Vaccines Revenue, 2023-2028
  4.2.3 By Type - Global Human Rabies Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Human Rabies Vaccines Sales & Forecasts
  4.3.1 By Type - Global Human Rabies Vaccines Sales, 2017-2022
  4.3.2 By Type - Global Human Rabies Vaccines Sales, 2023-2028
  4.3.3 By Type - Global Human Rabies Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Human Rabies Vaccines Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Human Rabies Vaccines Market Size, 2021 & 2028
  5.1.2 Pre-Exposure Prophylaxis
  5.1.3 Post-Exposure Prophylaxis
5.2 By Application - Global Human Rabies Vaccines Revenue & Forecasts
  5.2.1 By Application - Global Human Rabies Vaccines Revenue, 2017-2022
  5.2.2 By Application - Global Human Rabies Vaccines Revenue, 2023-2028
  5.2.3 By Application - Global Human Rabies Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Human Rabies Vaccines Sales & Forecasts
  5.3.1 By Application - Global Human Rabies Vaccines Sales, 2017-2022
  5.3.2 By Application - Global Human Rabies Vaccines Sales, 2023-2028
  5.3.3 By Application - Global Human Rabies Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Human Rabies Vaccines Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Human Rabies Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Human Rabies Vaccines Revenue & Forecasts
  6.2.1 By Region - Global Human Rabies Vaccines Revenue, 2017-2022
  6.2.2 By Region - Global Human Rabies Vaccines Revenue, 2023-2028
  6.2.3 By Region - Global Human Rabies Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Human Rabies Vaccines Sales & Forecasts
  6.3.1 By Region - Global Human Rabies Vaccines Sales, 2017-2022
  6.3.2 By Region - Global Human Rabies Vaccines Sales, 2023-2028
  6.3.3 By Region - Global Human Rabies Vaccines Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Human Rabies Vaccines Revenue, 2017-2028
  6.4.2 By Country - North America Human Rabies Vaccines Sales, 2017-2028
  6.4.3 US Human Rabies Vaccines Market Size, 2017-2028
  6.4.4 Canada Human Rabies Vaccines Market Size, 2017-2028
  6.4.5 Mexico Human Rabies Vaccines Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Human Rabies Vaccines Revenue, 2017-2028
  6.5.2 By Country - Europe Human Rabies Vaccines Sales, 2017-2028
  6.5.3 Germany Human Rabies Vaccines Market Size, 2017-2028
  6.5.4 France Human Rabies Vaccines Market Size, 2017-2028
  6.5.5 U.K. Human Rabies Vaccines Market Size, 2017-2028
  6.5.6 Italy Human Rabies Vaccines Market Size, 2017-2028
  6.5.7 Russia Human Rabies Vaccines Market Size, 2017-2028
  6.5.8 Nordic Countries Human Rabies Vaccines Market Size, 2017-2028
  6.5.9 Benelux Human Rabies Vaccines Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Human Rabies Vaccines Revenue, 2017-2028
  6.6.2 By Region - Asia Human Rabies Vaccines Sales, 2017-2028
  6.6.3 China Human Rabies Vaccines Market Size, 2017-2028
  6.6.4 Japan Human Rabies Vaccines Market Size, 2017-2028
  6.6.5 South Korea Human Rabies Vaccines Market Size, 2017-2028
  6.6.6 Southeast Asia Human Rabies Vaccines Market Size, 2017-2028
  6.6.7 India Human Rabies Vaccines Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Human Rabies Vaccines Revenue, 2017-2028
  6.7.2 By Country - South America Human Rabies Vaccines Sales, 2017-2028
  6.7.3 Brazil Human Rabies Vaccines Market Size, 2017-2028
  6.7.4 Argentina Human Rabies Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Human Rabies Vaccines Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Human Rabies Vaccines Sales, 2017-2028
  6.8.3 Turkey Human Rabies Vaccines Market Size, 2017-2028
  6.8.4 Israel Human Rabies Vaccines Market Size, 2017-2028
  6.8.5 Saudi Arabia Human Rabies Vaccines Market Size, 2017-2028
  6.8.6 UAE Human Rabies Vaccines Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Sanofi Pasteur?Inc.
  7.1.1 Sanofi Pasteur?Inc. Corporate Summary
  7.1.2 Sanofi Pasteur?Inc. Business Overview
  7.1.3 Sanofi Pasteur?Inc. Human Rabies Vaccines Major Product Offerings
  7.1.4 Sanofi Pasteur?Inc. Human Rabies Vaccines Sales and Revenue in Global (2017-2022)
  7.1.5 Sanofi Pasteur?Inc. Key News
7.2 Novartis Vaccines and Diagnostics Ltd.
  7.2.1 Novartis Vaccines and Diagnostics Ltd. Corporate Summary
  7.2.2 Novartis Vaccines and Diagnostics Ltd. Business Overview
  7.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Major Product Offerings
  7.2.4 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales and Revenue in Global (2017-2022)
  7.2.5 Novartis Vaccines and Diagnostics Ltd. Key News
7.3 Cadila Pharmaceuticals Ltd.
  7.3.1 Cadila Pharmaceuticals Ltd. Corporate Summary
  7.3.2 Cadila Pharmaceuticals Ltd. Business Overview
  7.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Major Product Offerings
  7.3.4 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales and Revenue in Global (2017-2022)
  7.3.5 Cadila Pharmaceuticals Ltd. Key News
7.4 GlaxoSmithKline Biologicals
  7.4.1 GlaxoSmithKline Biologicals Corporate Summary
  7.4.2 GlaxoSmithKline Biologicals Business Overview
  7.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Major Product Offerings
  7.4.4 GlaxoSmithKline Biologicals Human Rabies Vaccines Sales and Revenue in Global (2017-2022)
  7.4.5 GlaxoSmithKline Biologicals Key News
7.5 Merck?Co Inc.
  7.5.1 Merck?Co Inc. Corporate Summary
  7.5.2 Merck?Co Inc. Business Overview
  7.5.3 Merck?Co Inc. Human Rabies Vaccines Major Product Offerings
  7.5.4 Merck?Co Inc. Human Rabies Vaccines Sales and Revenue in Global (2017-2022)
  7.5.5 Merck?Co Inc. Key News
7.6 Wyeth pharmaceuticals
  7.6.1 Wyeth pharmaceuticals Corporate Summary
  7.6.2 Wyeth pharmaceuticals Business Overview
  7.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Major Product Offerings
  7.6.4 Wyeth pharmaceuticals Human Rabies Vaccines Sales and Revenue in Global (2017-2022)
  7.6.5 Wyeth pharmaceuticals Key News
7.7 Berna Biotech Ltd.
  7.7.1 Berna Biotech Ltd. Corporate Summary
  7.7.2 Berna Biotech Ltd. Business Overview
  7.7.3 Berna Biotech Ltd. Human Rabies Vaccines Major Product Offerings
  7.7.4 Berna Biotech Ltd. Human Rabies Vaccines Sales and Revenue in Global (2017-2022)
  7.7.5 Berna Biotech Ltd. Key News
7.8 Medimmune LLC
  7.8.1 Medimmune LLC Corporate Summary
  7.8.2 Medimmune LLC Business Overview
  7.8.3 Medimmune LLC Human Rabies Vaccines Major Product Offerings
  7.8.4 Medimmune LLC Human Rabies Vaccines Sales and Revenue in Global (2017-2022)
  7.8.5 Medimmune LLC Key News

8 GLOBAL HUMAN RABIES VACCINES PRODUCTION CAPACITY, ANALYSIS

8.1 Global Human Rabies Vaccines Production Capacity, 2017-2028
8.2 Human Rabies Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Rabies Vaccines Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 HUMAN RABIES VACCINES SUPPLY CHAIN ANALYSIS

10.1 Human Rabies Vaccines Industry Value Chain
10.2 Human Rabies Vaccines Upstream Market
10.3 Human Rabies Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Human Rabies Vaccines Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Human Rabies Vaccines in Global Market
Table 2. Top Human Rabies Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Rabies Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Rabies Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Human Rabies Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Human Rabies Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Rabies Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Human Rabies Vaccines Product Type
Table 9. List of Global Tier 1 Human Rabies Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Rabies Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Rabies Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Rabies Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Rabies Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Rabies Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Human Rabies Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Human Rabies Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Rabies Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Rabies Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Rabies Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Human Rabies Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Human Rabies Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Rabies Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Rabies Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Rabies Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Human Rabies Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Human Rabies Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Rabies Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Rabies Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Human Rabies Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Human Rabies Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Rabies Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Rabies Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Human Rabies Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Human Rabies Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Rabies Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Rabies Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Human Rabies Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Human Rabies Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Rabies Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Rabies Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Human Rabies Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Human Rabies Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Rabies Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Rabies Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Human Rabies Vaccines Sales, (K Units), 2023-2028
Table 46. Sanofi Pasteur?Inc. Corporate Summary
Table 47. Sanofi Pasteur?Inc. Human Rabies Vaccines Product Offerings
Table 48. Sanofi Pasteur?Inc. Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Novartis Vaccines and Diagnostics Ltd. Corporate Summary
Table 50. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product Offerings
Table 51. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Cadila Pharmaceuticals Ltd. Corporate Summary
Table 53. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product Offerings
Table 54. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. GlaxoSmithKline Biologicals Corporate Summary
Table 56. GlaxoSmithKline Biologicals Human Rabies Vaccines Product Offerings
Table 57. GlaxoSmithKline Biologicals Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Merck?Co Inc. Corporate Summary
Table 59. Merck?Co Inc. Human Rabies Vaccines Product Offerings
Table 60. Merck?Co Inc. Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Wyeth pharmaceuticals Corporate Summary
Table 62. Wyeth pharmaceuticals Human Rabies Vaccines Product Offerings
Table 63. Wyeth pharmaceuticals Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Berna Biotech Ltd. Corporate Summary
Table 65. Berna Biotech Ltd. Human Rabies Vaccines Product Offerings
Table 66. Berna Biotech Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Medimmune LLC Corporate Summary
Table 68. Medimmune LLC Human Rabies Vaccines Product Offerings
Table 69. Medimmune LLC Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Human Rabies Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global Human Rabies Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Human Rabies Vaccines Production by Region, 2017-2022 (K Units)
Table 73. Global Human Rabies Vaccines Production by Region, 2023-2028 (K Units)
Table 74. Human Rabies Vaccines Market Opportunities & Trends in Global Market
Table 75. Human Rabies Vaccines Market Drivers in Global Market
Table 76. Human Rabies Vaccines Market Restraints in Global Market
Table 77. Human Rabies Vaccines Raw Materials
Table 78. Human Rabies Vaccines Raw Materials Suppliers in Global Market
Table 79. Typical Human Rabies Vaccines Downstream
Table 80. Human Rabies Vaccines Downstream Clients in Global Market
Table 81. Human Rabies Vaccines Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Human Rabies Vaccines Segment by Type
Figure 2. Human Rabies Vaccines Segment by Application
Figure 3. Global Human Rabies Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Rabies Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Rabies Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Rabies Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Rabies Vaccines Revenue in 2021
Figure 9. By Type - Global Human Rabies Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Rabies Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Rabies Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Human Rabies Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Rabies Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Rabies Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Human Rabies Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Rabies Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Rabies Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Rabies Vaccines Sales Market Share, 2017-2028
Figure 19. US Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Rabies Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Rabies Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Rabies Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Rabies Vaccines Sales Market Share, 2017-2028
Figure 33. China Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Rabies Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Rabies Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Rabies Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Rabies Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Rabies Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Rabies Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Human Rabies Vaccines by Region, 2021 VS 2028
Figure 50. Human Rabies Vaccines Industry Value Chain
Figure 51. Marketing Channels